https://www.mikhailblagosklonnyoncotarget.com/2020/10/02/thanks-to-impact-journals-we-know-exercise-helps-to-fight-breast-cancer-for-free/ 2020-12-15T19:21:59+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2020/12/04/oncotarget-launches-new-special-collection-on-breast-cancer/ 2020-12-15T19:24:12+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2020/12/11/special-collection-by-oncotarget-lung-cancer/ 2021-01-07T15:01:07+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2020/12/31/trending-with-impact-review-of-her2-variants-in-breast-cancer-tumors/ 2021-01-07T14:59:43+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/01/07/trending-with-impact-nimotuzumab-improves-non-hpv-oropharynx-cancers/ 2021-01-07T15:35:58+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/01/14/trending-with-impact-rna-seq-analyses-show-targets-in-b-cell-lymphoma/ 2021-01-15T20:45:59+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/01/21/trending-with-impact-bacterial-therapy-experiments-in-prostate-cancer/ 2021-01-21T19:16:58+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/01/29/trending-with-impact-new-plant-extracts-reveal-anti-aging-properties/ 2021-01-29T13:54:19+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/02/04/is-the-key-to-cancer-prevention-anti-aging-drugs/ 2021-02-04T13:51:46+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/02/04/trending-with-impact-novel-microrna-underexpressed-in-lung-cancer/ 2021-02-09T22:15:21+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/02/09/an-overview-of-cannabis-and-cancer/ 2021-02-09T22:16:02+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/02/16/trending-with-impact-new-prognostic-parameters-for-breast-cancer/ 2021-02-18T20:43:24+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/02/18/trending-with-impact-murine-model-of-cancer-derived-myocardial-damage/ 2021-02-19T17:58:10+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/02/25/trending-with-impact-crosstalk-in-the-tumor-microenvironment/ 2021-02-26T17:01:33+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/03/08/trending-with-impact-machine-learning-used-to-compare-alk-inhibitors/ 2021-03-08T15:26:15+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/03/11/trending-with-impact-hepatocellular-carcinoma-in-the-andes-mountains/ 2021-03-11T23:21:14+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/03/19/trending-with-impact-benign-borderline-and-malignant-breast-tumors/ 2021-03-19T14:02:58+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/03/26/oncotarget-participating-in-virtual-aacr-2021-annual-meeting/ 2021-04-02T19:04:30+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/04/08/trending-with-impact-the-vitamin-d-binding-protein-in-thyroid-cancer/ 2021-04-08T19:53:57+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/04/23/trending-with-impact-acute-myeloid-leukemia-and-midostaurin-response/ 2021-04-27T18:15:02+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/05/07/trending-with-impact-composite-score-may-further-classify-hcc/ 2021-05-08T16:40:23+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/05/20/trending-with-impact-rna-modification-regulatory-proteins-in-melanoma/ 2021-05-21T18:14:04+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/06/04/trending-with-impact-novel-biomarkers-in-bladder-cancer/ 2021-07-15T23:43:56+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/06/18/trending-with-impact-low-dose-chemo-inhibits-resistant-breast-cancer/ 2021-07-15T23:41:30+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/07/01/trending-with-impact-onc201-induces-apoptosis-in-breast-cancer/ 2021-07-01T22:07:13+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/07/15/trending-with-impact-targeted-treatment-for-recurrent-ovarian-cancer/ 2021-07-16T14:29:32+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/07/15/oncotarget-uses-trendmd-to-expand-research-impact/ 2021-07-15T23:55:19+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/07/28/the-ride-for-roswell-rolling-around-the-track-august-7/ 2021-08-03T21:12:38+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/08/16/trending-with-impact-analysis-of-breast-cancer-in-nigerian-women/ 2021-08-16T12:58:15+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/08/18/captain-of-team-open-access-rides-again-for-cancer-research/ 2021-08-18T15:41:27+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/08/26/trending-with-impact-promising-non-small-cell-lung-cancer-prodrug/ 2021-09-01T18:21:33+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/10/04/trending-with-impact-unconventional-method-effectively-targets-nsclc/ 2021-10-04T20:37:53+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/10/21/emt-resistance-in-cancer-cells-and-two-potential-causes/ 2021-10-28T13:45:41+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/10/27/new-study-vaccine-enhances-breast-cancer-treatment/ 2021-11-03T14:11:00+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/11/10/new-study-alk-rearrangement-among-lung-cancer-patients/ 2021-11-11T15:28:10+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/11/18/sunscreen-ingredient-promotes-breast-cancer-in-diet-dependent-manner/ 2021-11-18T22:53:17+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/12/16/could-metformin-and-rapamycin-replace-maintenance-chemotherapy/ 2021-12-16T21:43:30+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2021/12/31/can-purified-cholera-stop-obesity/ 2022-01-03T22:07:08+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/01/06/open-access-oncotarget-shifts-to-continuous-publishing/ 2022-01-06T15:37:45+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/01/13/gene-mutations-and-neoantigens-in-head-and-neck-tumors/ 2022-01-14T18:22:41+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/01/21/oncotargets-top-10-papers-of-2021/ 2022-02-09T22:07:01+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/01/26/prognostic-markers-identified-in-ultra-rare-adrenal-cancer/ 2022-02-02T12:33:26+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/02/02/what-causes-chemo-brain/ 2022-02-02T17:19:28+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/02/10/iron-chelators-in-cancer-treatment/ 2022-02-10T21:00:24+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/02/17/trending-with-impact-new-pre-transplant-aml-treatment-combinations/ 2022-02-18T00:11:02+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/02/24/trending-with-impact-are-notch1-variants-prognostic-in-breast-cancer/ 2022-02-24T21:23:48+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/03/09/a-remote-weight-loss-strategy-for-breast-cancer-survivors/ 2022-03-10T19:08:00+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/03/17/trending-with-impact-adjunct-virotherapy-fights-multiple-myeloma/ 2022-03-18T17:33:18+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/03/24/trending-with-impact-interrelated-oncogenic-pathways-in-osteosarcoma/ 2022-03-25T16:08:55+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/04/06/novel-therapeutic-strategies-against-endometrial-cancer/ 2022-04-07T17:20:27+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/04/15/trending-with-impact-genes-identified-in-endocrine-therapy-resistance/ 2022-04-17T12:45:05+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/04/21/trending-with-impact-analysis-of-mutational-burden-in-nsclc/ 2022-04-26T13:10:25+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/04/28/gene-variants-investigated-in-polish-bladder-and-kidney-cancer/ 2022-04-28T23:18:21+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/05/13/trending-with-impact-dual-requirement-in-stem-cell-leukemia-lymphoma/ 2022-05-18T15:08:58+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/05/26/new-tool-uses-nf-%ce%bab-activity-to-classify-hpv-head-and-neck-cancer/ 2022-05-26T20:34:45+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/07/15/how-heartburn-can-turn-into-esophageal-cancer-and-a-possible-biomarker/ 2022-07-15T17:44:59+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/08/05/does-a-mechanism-linking-cellular-aging-to-cellular-quiescence-exist/ 2022-08-09T07:24:45+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/08/24/epigenetics-and-immunotherapy-combined-fights-rare-lymphoma/ 2022-08-25T12:44:07+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/09/01/immunotherapy-response-predicted-by-machine-learning-gut-microbiomes/ 2022-09-01T18:35:58+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/09/23/protein-based-risk-model-predicts-esophageal-cancer-recurrence/ 2022-09-26T18:27:32+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/09/27/how-high-altitudes-influence-hif-1-gastric-cancer-patient-survival/ 2022-09-28T19:17:55+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/10/07/crispr-screens-identify-novel-targets-for-personalized-cancer-therapy/ 2022-10-10T20:23:30+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/10/19/synergy-of-hdaci-parpi-and-chemotherapeutics-against-blood-cancer/ 2022-10-19T14:11:52+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/11/02/new-target-fights-ferroptosis-and-radio-resistance-in-lung-cancers/ 2022-11-02T19:08:06+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/11/15/biomarkers-may-predict-neoadjuvant-chemosensitivity-in-bladder-cancer/ 2022-11-15T23:22:26+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/12/08/plasma-growth-hormone-in-hcc-a-biomarker-of-response-to-atezo-bev/ 2022-12-09T20:38:45+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2022/12/20/a-new-method-of-targeting-exosomes-in-precision-medicine/ 2022-12-21T18:44:14+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/01/04/novel-antibody-drug-conjugate-improves-murine-acute-myeloid-leukemia/ 2023-01-05T15:07:12+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/01/19/researchers-identify-new-drug-candidates-to-treat-dlst-tumors/ 2023-01-19T21:59:51+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/02/02/the-importance-of-cd56-in-the-fight-against-multiple-myeloma/ 2023-02-03T18:48:27+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/02/16/controlling-glycolytic-flux-therapy-challenges-and-solutions/ 2023-02-17T14:52:56+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/02/22/oncotargets-top-10-papers-in-2022-crossref-data/ 2023-02-22T21:04:51+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/03/01/the-role-of-kras-and-canonical-wnt-pathways-in-biliary-tract-cancers/ 2023-03-02T21:26:15+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/03/16/unconventional-protein-secretion-ups-in-cancer/ 2023-03-17T13:09:49+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/03/31/targeting-pre-leukemic-cells-new-hope-for-preventing-childhood-b-all/ 2023-03-31T20:04:36+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/04/14/the-evolution-of-metastatic-cancer-mechanisms-and-drivers/ 2023-04-17T18:46:49+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/04/27/defining-the-complexity-of-egfr-endocytosis-in-cancer/ 2023-04-28T19:08:58+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/05/11/reaching-the-brain-through-the-groin-a-novel-approach-to-brain-cancer/ 2023-05-12T19:55:16+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/05/25/can-the-creatine-shuttle-be-targeted-to-fight-colorectal-cancer/ 2023-05-27T00:26:35+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/06/16/new-study-reveals-genetic-risk-factors-for-cancer-in-saudi-arabia/ 2023-06-29T16:45:04+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/06/29/novel-gem-model-unveils-plk1s-role-in-tumorigenesis/ 2023-06-30T18:41:16+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/07/14/targeting-ras-in-cancer-therapies-advances-in-protein-engineering/ 2023-07-14T14:51:41+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/07/27/the-obesity-paradox-metformin-and-lung-cancer/ 2023-07-27T20:35:02+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/08/10/whole-genome-doubling-and-aneuploidy-in-human-cancer/ 2023-08-10T21:50:01+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/09/07/dr-mikhail-blagosklonny-on-rapamycin-longevity-series/ 2023-09-07T17:06:07+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/09/07/predicting-functions-of-cancer-associated-genetic-variants/ 2023-09-07T20:43:35+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/09/21/targeting-fatty-acid-binding-proteins-in-multiple-myeloma/ 2023-09-21T20:47:34+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/10/05/genetic-insights-into-early-breast-cancer-in-kazakhstan/ 2023-10-05T20:12:51+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/10/19/how-a-metabolic-enzyme-can-trigger-cell-death-in-liver-cancer-cells/ 2023-10-20T00:08:45+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/11/02/p53s-protective-role-in-extrahepatic-biliary-precancerous-lesions/ 2023-11-02T19:45:32+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/11/16/immunotherapy-response-in-primary-vs-metastatic-pancreatic-cancer/ 2023-11-16T22:37:57+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/11/29/can-mechanisms-of-hair-loss-shed-light-on-cancer-and-aging/ 2023-11-29T20:12:28+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/12/14/triple-combination-treatment-overcomes-colorectal-cancer-resistance/ 2023-12-14T20:18:47+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2023/12/28/melatonin-in-cancer-therapy-lessons-from-50-years-of-research/ 2023-12-29T01:17:19+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/01/11/how-osteopontin-stimulates-mitochondrial-biogenesis-and-cancer-metastasis/ 2024-01-11T19:42:40+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/01/22/dr-blagosklonnys-battle-with-cancer-part-1/ 2024-01-23T16:11:51+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/01/25/new-drug-may-boost-effectiveness-of-glioblastoma-treatment/ 2024-01-25T20:52:43+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/02/08/genetic-alterations-in-thyroid-cancer-resistance-to-brafi-and-anaplastic-transformation/ 2024-02-08T22:04:11+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/02/15/oncotargets-top-10-papers-published-in-2023-crossref-data/ 2024-02-16T15:37:39+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/02/23/raw-areca-nut-betel-quid-consumption-and-esophageal-cancer/ 2024-02-23T00:35:46+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/03/14/antitumor-effects-of-sacituzumab-govitecan-plus-platinum-based-chemotherapy/ 2024-03-14T19:27:28+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/03/28/identifying-biomarkers-for-predicting-paclitaxel-response/ 2024-03-28T20:16:48+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/04/11/synergistic-effects-of-drug-combinations-targeting-aml-cells/ 2024-04-12T13:32:21+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/05/09/sars-cov-2-spike-protein-disrupts-p53-tumor-suppressor-pathway/ 2024-05-09T19:26:20+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/05/23/combating-doxorubicin-resistant-acute-myeloid-leukemia/ 2024-05-23T18:12:12+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/06/06/dr-blagosklonnys-strategy-from-osimertinib-to-preemptive-combinations/ 2024-06-06T18:43:51+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/06/20/impact-of-dual-immunotherapies-before-surgery-in-hr-her2-negative-breast-cancer/ 2024-06-20T20:30:57+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/07/11/ai-for-improved-pet-ct-attenuation-correction-in-prostate-cancer-imaging/ 2024-07-11T21:24:06+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/07/25/novel-triple-drug-combination-to-fight-pancreatic-cancer/ 2024-07-25T18:06:58+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/08/09/combining-regorafenib-and-tas102-to-target-gastrointestinal-cancers-and-overcome-cancer-stemness/ 2024-08-09T18:20:11+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/08/28/key-roles-of-mif-ddt-and-cd74-in-melanoma-prognosis-and-therapy/ 2024-08-28T16:23:57+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/09/12/harnessing-the-power-of-nanobodies-inhibiting-metastasis-of-4t1-12b-breast-tumor-cells/ 2024-09-13T13:50:34+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/09/26/cdr3s-and-renalase-1-correlate-with-increased-melanoma-survival/ 2024-09-26T16:46:13+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/10/11/targeting-stem-cell-like-traits-how-mir-10b-inhibition-treats-metastatic-breast-cancer/ 2024-10-11T16:46:38+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/10/22/tribute-to-dr-mikhail-misha-blagosklonny/ 2024-11-07T17:46:57+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/10/24/next-generation-antibodies-for-cancer-therapy/ 2024-10-24T16:27:23+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/11/13/cancer-dormancy-and-tumor-recurrence-new-insights-for-breast-cancer/ 2024-11-13T18:41:39+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/12/04/small-cell-lung-cancer-advancing-precision-medicine-with-biomarker-research/ 2024-12-04T17:26:32+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2024/12/18/a-new-path-to-tumor-suppression-the-promise-of-pg3/ 2024-12-18T16:49:56+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/01/03/the-hidden-risks-of-at-home-genetic-cancer-tests/ 2025-01-03T18:59:15+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/01/15/mastocytosis-key-insights-into-kit-m541l-gene-mutation/ 2025-01-15T15:08:20+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/01/16/dr-mikhail-blagosklonnys-legacy-hyperfunction-theory-and-rapamycin/ 2025-01-16T10:54:36+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/01/28/a-new-approach-for-cancer-treatment-the-surprising-relationship-between-klrg1-and-pd-1/ 2025-02-12T14:23:11+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/02/12/her2-low-breast-cancer-a-new-understanding/ 2025-02-12T15:03:28+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/02/26/how-a-simple-blood-test-could-predict-colorectal-cancer-surgery-success/ 2025-02-26T20:07:12+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/03/12/a-rare-genetic-shift-that-helped-lung-cancer-evade-treatment/ 2025-03-12T15:56:38+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/03/26/when-the-cure-becomes-the-cause-a-rare-case-of-cancer-from-donor-cells/ 2025-03-26T16:29:32+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/04/03/call-for-papers-special-collection-honoring-dr-mikhail-misha-blagosklonny/ 2025-12-18T15:42:12+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/04/09/targeting-setdb1-a-new-strategy-for-treating-osteosarcoma/ 2025-04-09T13:43:07+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/04/22/new-insights-into-p53-a-powerful-genes-role-in-cancer-therapy/ 2025-04-22T19:48:36+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/05/07/panitumumab-and-low-dose-capecitabine-a-promising-maintenance-therapy-for-metastatic-colorectal-cancer/ 2025-05-07T19:19:10+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/05/21/engineered-proteins-show-promise-in-stopping-glioblastoma-invasion/ 2025-05-21T15:23:07+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/06/04/experimental-triple-therapy-improves-survival-in-glioblastoma-mouse-model/ 2025-06-04T18:28:19+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/06/10/oncotarget-sponsors-open-access-team-in-2025-ride-for-roswell/ 2025-06-10T17:25:53+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/06/16/exploring-a-combined-approach-radiation-and-immunotherapy-in-bladder-cancer/ 2025-06-16T20:53:43+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/07/02/immunotherapy-safety-for-hepatocellular-carcinoma-in-latin-america-insights-from-a-real-world-study/ 2025-07-02T15:28:42+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/07/14/prdx1-identified-as-key-to-chemotherapy-resistance-in-cancer-cells/ 2025-07-14T14:05:05+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/07/29/a-new-way-to-target-resistant-prostate-cancer-cells/ 2025-07-29T20:31:52+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/08/11/cigarette-smoke-and-weak-dna-repair-a-double-hit-behind-lung-cancer-risk/ 2025-08-26T14:16:41+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/08/26/amivantamab-monotherapy-in-rare-egfr-mutated-advanced-nsclc/ 2025-08-26T14:43:00+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/09/11/immunotherapy-response-in-pancreatic-cancer-what-a-new-study-reveals/ 2025-09-11T15:03:06+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/09/24/precision-oncology-in-metastatic-colorectal-cancer-a-real-world-case-study/ 2025-09-24T14:30:52+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/10/08/new-insights-into-her2-mutated-non-small-cell-lung-cancer-in-brazil/ 2025-10-08T15:49:03+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/10/22/genetic-study-identifies-potential-diagnostic-marker-for-rare-blood-cancer-bpdcn/ 2025-10-22T14:40:17+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/11/06/how-low-oxygen-shields-prostate-cancer-from-ferroptosis-therapies/ 2025-11-06T15:44:49+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/11/19/new-antibody-removes-tregs-to-boost-immune-response-against-cancer/ 2025-11-19T15:44:17+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/12/03/how-two-russian-scientists-changed-the-way-we-understand-aging-and-cancer/ 2025-12-03T10:23:10+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/12/03/repurposing-statins-exploring-anti-tumor-effects-in-colorectal-cancer/ 2025-12-03T15:35:22+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2025/12/15/comprehensive-genomic-profiling-in-cancer-insights-from-over-10000-tumors/ 2025-12-15T16:33:36+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2026/01/13/overcoming-aromatase-inhibitor-resistance-in-breast-cancer-a-new-therapeutic-strategy/ 2026-01-13T16:41:24+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2026/01/20/how-aging-leads-to-disease-new-two-stage-model-explains-age-related-illness/ 2026-01-20T07:46:08+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2026/01/26/exploring-possible-links-between-covid-19-vaccination-infection-and-cancer/ 2026-01-26T15:15:39+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2026/02/09/how-hpv-and-covid-19-spike-proteins-may-interact-to-impact-cancer-suppression/ 2026-02-09T16:41:28+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2026/02/27/mrna-covid-19-vaccination-and-cancer-risk-a-case-based-review/ 2026-02-27T17:42:12+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2026/03/10/car-t-cell-therapy-a-revolutionary-approach-to-cancer-treatment/ 2026-03-10T15:38:56+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2026/03/25/predicting-colorectal-cancer-survival-how-machine-learning-combines-clinical-and-biological-clues/ 2026-03-25T17:14:45+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2026/04/07/creb5-a-master-regulator-of-stem-cell-like-programs-in-prostate-cancer-progression/ 2026-04-07T17:15:42+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2026/04/10/oncotarget-editorial-highlights-advances-in-scientific-integrity-and-publishing-transparency/ 2026-04-19T10:46:53+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2026/04/21/scd1-inhibition-strategy-shows-potent-synergy-with-regorafenib-and-metformin-in-tumor-cell-killing/ 2026-04-21T18:24:52+00:00 monthly 0.2 https://www.mikhailblagosklonnyoncotarget.com/2026/05/05/mapping-the-hidden-structure-of-glioma-research-what-are-we-missing/ 2026-05-05T15:34:15+00:00 monthly 0.2